(Q77535805)

English

A randomized comparison of bivalirudin and heparin in patients undergoing coronary angioplasty for postinfarction angina. Hirulog Angioplasty Study Investigators

scientific article published on 01 October 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9809891%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

A randomized comparison of bivalirudin and heparin in patients undergoing coronary angioplasty for postinfarction angina. Hirulog Angioplasty Study Investigators (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9809891%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

J A Bittl

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9809891%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

F Feit

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9809891%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

publication date

1 October 1998

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9809891%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

American Journal of Cardiology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9809891%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

82

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9809891%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

8B

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9809891%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

43P-49P

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9809891%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

Acute coronary artery occlusion during and after percutaneous transluminal coronary angioplasty. Frequency, prediction, clinical course, management, and follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900766-8

7 January 2021

Incidence and consequences of periprocedural occlusion. The 1985-1986 National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900766-8

7 January 2021

Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900766-8

7 January 2021

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900766-8

7 January 2021

Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900766-8

7 January 2021

Abrupt vessel closure complicating coronary angioplasty: clinical, angiographic and therapeutic profile

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900766-8

7 January 2021

Length of hospital stay and complications after percutaneous transluminal coronary angioplasty. Clinical and procedural predictors. Heparin Registry Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900766-8

7 January 2021

Predicting the risk of abrupt vessel closure after angioplasty in an individual patient

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900766-8

7 January 2021

The relationship of anticoagulation level and complications after successful percutaneous transluminal coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900766-8

7 January 2021

Lesion morphology and coronary angioplasty: current experience and analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900766-8

7 January 2021

Use of a direct antithrombin, hirulog, in place of heparin during coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900766-8

7 January 2021

In vivo thrombus formation on a guidewire during intravascular ultrasound imaging: evidence for inadequate heparinization.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900766-8

7 January 2021

Relation between procedural activated coagulation time and outcome after percutaneous transluminal coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900766-8

7 January 2021

Relation between activated clotting time during angioplasty and abrupt closure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900766-8

7 January 2021

Relation between abrupt vessel closure and the anticoagulant response to heparin or bivalirudin during coronary angioplasty.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900766-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900766-8

7 January 2021

Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900766-8

7 January 2021

Heparin neutralization by platelet-rich thrombi. Role of platelet factor 4

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900766-8

7 January 2021

Anticoagulant effects of hirulog, a novel thrombin inhibitor, in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900766-8

7 January 2021

Hirulog in the treatment of unstable angina. Results of the Thrombin Inhibition in Myocardial Ischemia (TIMI) 7 trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900766-8

7 January 2021

Initial experience with a direct antithrombin, Hirulog, in unstable angina. Anticoagulant, antithrombotic, and clinical effects

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900766-8

7 January 2021

A pilot, early angiographic patency study using a direct thrombin inhibitor as adjunctive therapy to streptokinase in acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900766-8

7 January 2021

Usefulness and tolerability of hirulog, a direct thrombin-inhibitor, in unstable angina pectoris.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900766-8

7 January 2021

Randomized double-blind comparison of two doses of Hirulog with heparin as adjunctive therapy to streptokinase to promote early patency of the infarct-related artery in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900766-8

7 January 2021

Treatment with bivalirudin (Hirulog) as compared with heparin during coronary angioplasty for unstable or postinfarction angina. Hirulog Angioplasty Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900766-8

7 January 2021

Electrocardiographic classification for population comparisons. The Minnesota code.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900766-8

7 January 2021

The prognostic importance of the electrocardiogram after myocardial infarction. Experience in the Coronary Drug Project

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900766-8

7 January 2021

Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900766-8

7 January 2021

Immediate vs delayed catheterization and angioplasty following thrombolytic therapy for acute myocardial infarction. TIMI II A results. The TIMI Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900766-8

7 January 2021

Intracoronary stenting for acute and threatened closure complicating percutaneous transluminal coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900766-8

7 January 2021

Relation between clinical presentation and angiographic findings in unstable angina pectoris, and comparison with that in stable angina

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900766-8

7 January 2021

Accuracy of electronic digital calipers compared with quantitative angiography in measuring coronary arterial diameter

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900766-8

7 January 2021

Guidelines for percutaneous transluminal coronary angioplasty. A report of the American Heart Association/American College of Cardiology Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Percutaneous Tran

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900766-8

7 January 2021

Randomized, double-blind comparison of hirulog versus heparin in patients receiving streptokinase and aspirin for acute myocardial infarction (HERO). Hirulog Early Reperfusion/Occlusion (HERO) Trial Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900766-8

7 January 2021

Antithrombotic therapy in patients undergoing coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900766-8

7 January 2021

A comparison of hirudin with heparin in the prevention of restenosis after coronary angioplasty. Helvetica Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900766-8

7 January 2021

Direct thrombin inhibitors in cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900766-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0002-9149(98)00766-8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9809891%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9809891%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q77535805&oldid=1585766783"